Cargando…
Two conformationally distinct α-synuclein oligomers share common epitopes and the ability to impair long-term potentiation
Parkinson’s Disease (PD) is a neurodegenerative disease for which there currently is no cure. Aggregation of the pre-synaptic protein α-synuclein (aSN) into oligomers (αSOs) is believed to play a key role in PD pathology, but little is known about αSO formation in vivo and how they induce neurodegen...
Autores principales: | van Diggelen, Femke, Hrle, Dean, Apetri, Mihaela, Christiansen, Gunna, Rammes, Gerhard, Tepper, Armand, Otzen, Daniel Erik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430514/ https://www.ncbi.nlm.nih.gov/pubmed/30901378 http://dx.doi.org/10.1371/journal.pone.0213663 |
Ejemplares similares
-
Reducing the Amyloidogenicity of Functional Amyloid
Protein FapC Increases Its Ability To Inhibit α-Synuclein
Fibrillation
por: Christensen, Line Friis Bakmann, et al.
Publicado: (2019) -
Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers
por: Kayed, Rakez, et al.
Publicado: (2007) -
Drug repurposing screens identify compounds that inhibit α-synuclein oligomers' membrane disruption and block antibody interactions
por: Somavarapu, Arun Kumar, et al.
Publicado: (2023) -
Optimizing Epitope Conformational Ensembles Using
α-Synuclein Cyclic Peptide “Glycindel”
Scaffolds: A Customized Immunogen Method for Generating Oligomer-Selective
Antibodies for Parkinson’s Disease
por: Hsueh, Shawn C. C., et al.
Publicado: (2022) -
A penetratin-derived peptide reduces the membrane permeabilization and cell toxicity of α-synuclein oligomers
por: Pirhaghi, Mitra, et al.
Publicado: (2022)